AHOD Publications
Time trends in antiretroviral treatment use in Australia, 1997-2000. The Australian HIV Observational Database
Venereology 2001;14:162-168.
Rates of change of combination antiretroviral treatment in Australia
The Australian HIV Observational Database. HIV Medicine 2002;3:28-36.
The role of observational data in monitoring trends in antiretroviral treatment and HIV disease stage: results from the Australian HIV Observational database
Petoumenos K on behalf of The Australian HIV Observational Database. Journal of Clinical Virology 2003;26:209-222.
HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral treatment
Lincoln D, Petoumenos K, Dore G on behalf of the Australian HIV Observational Database. HIV Medicine 2003;4:241-249.
Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database
Petoumenos K, Ringland C; on behalf of the Australian HIV Observational Database. HIV Medicine, 2005 May;6(3):155-63
Risk factors and causes of death in the Australian HIV Observational Database
K Petoumenos and M Law on behalf of the Australian HIV Observational Database. Sexual Health, 2006 May;3(2):103-12
AHOD collaborative publications
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes
The Plato Collaboration. Lancet. 2004 Jul 3;364(9428):51-62.
Nucleoside Analogue Use Before and During Highly Active Antiretroviral Therapy and Virus Load Rebound
Collaboration of HIV Cohorts. JID 2004: 190 (15 August) - 675
D:A:D Study publications
Modelling the three year risk of myocardial infarction among participants in the D:A:D study
Law M, Friis-Møller N, Weber R, Reiss P, Thiebaut R, Kirk O et al. HIV Med. 2003; 4(1):1-10.
Cardiovascular risk factors in HIV patients - association with antiretroviral therapy Results from the DAD Study
Friis-Møller N, Weber R, Reiss P, Thiebaut R, Kirk O, d'Arminio MA et al. AIDS. 2003,17:1179-1193
Lipid profiles in HIV-1-infected individuals receiving combination antiretroviral therapy: are different protease inhibitors or non-nucleoside reverse transcriptase inhibitors associated with different lipid profiles?
Fontas E, van Leth F, Sabin CA, Friis-Møller N, Rickenbach M, d'Arminio Monforte A, Kirk O, Dupon M, Morfeldt L, Mateu S, Petoumenos K, El-Sadr W, de Wit S, Lundgren JD, Pradier C, Reiss P. J Infect Dis. 2004;189(6):1056-1075
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction. The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group
Writing Committee: Friis-Moller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, Thiebaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Law MG, Kirk O, Phillips AN, Lundgren JD. N Engl J Med. 2003;349(21); 1993-2003.
Cardio- and Cerebrovascular Events in HIV-Infected Persons. The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group
Writing Committee: d'Arminio Monforte A, Sabin CA, Reiss P, Weber R, Kirk O, El-Sadr W, De Wit S, Mateu S, Petoumenos K, Dabis F, Pradier C, Morfeldt L, Phillips AN, Lundgren JD, and Friis-Moller N. AIDS 2004, 18:1811-1817